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ABSTRACT
Epidemiological studies suggested an association between obesity and sleep disturbances.
Obstructive sleep apnea is the most prevalent type of obesity-related sleep disorder that lead to
an increased risk for numerous chronic health conditions. In addition the increased visceral adi-
pose tissue might be responsible for the secretion of inflammatory cytokines that could contribute
to alter the sleep-wake rhythm. Unhealthy food characterized by high consumption of fat and
carbohydrate seems to negatively influence the quality of sleep while diet rich of fiber is associ-
ated to more restorative and deeper sleep. Although obesity could cause through several patho-
genetic mechanisms an alteration of sleep, it has been reported that subjects suffering from sleep
disorders are more prone to develop obesity. Experimental laboratory studies have demonstrated
that decreasing either the amount or quality of sleep increase the risk of developing obesity.
Experimental sleep restriction also causes physiological, hormonal and food behavioral changes
that promote a positive energy balance and a compensatory disproportionate increase in food
intake, decrease in physical activity, and weight gain. Thus, the aim of this review is to provide
observational evidence on the association of obesity with sleep disturbances and viceversa with
emphasis on possible pathophysiological mechanisms (hormonal and metabolic) that link these
two pathological conditions.
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1. Introduction
In the last decade, the prevalence of obesity increased sig-
nificantly in populations worldwide. A less dramatic, but
equally important increase has been seen in obesity-related
comorbidities (Type 2 diabetes, cardiovascular diseases, can-
cer) that are becoming a real burden for healthcare systems
(Bauer et al. 2014). In addition to the most common com-
plications of obesity, recently sleep disturbances rose to the
prominence as one of obesity-related complication
(Burman 2017).
In particular, obesity could increase the risk of developing
obstructive sleep apnea (OSA), a condition that appears to
independently increase metabolic impairment, including dysli-
pidaemia, insulin resistance and hypertension in both adults
(Tahrani 2017; Said, Mukherjee and Whayne 2016) and ado-
lescents (Patinkin, Feinn, and Santos 2017). Additionally,
Sleep Quality (SQ) has been reported to be blunted by
increased pro-inflammatory cytokines circulating levels, which
are often associated to obesity (Gamaldo, Shaikh and
McArthur 2012). Recent findings suggest that a further
important mechanism that links obesity to Sleep Disturbances
(SD) is represented by diet quality (Hargens et al. 2013), likely
through the effects of nutrients that act on inflammation and/
or hormonal responses involved in hunger-satiety mechanism,
energy metabolism and circadian rhythm.
In turn, a number of evidence showed that SD may
increase the risk of developing obesity and metabolic diseases,
including type 2 diabetes (T2DM) (Shan et al. 2015). Sleep
duration seems to be closely related to weight gain (Taheri
et al. 2004; Taheri 2006; Chen, Beydoun, and Wang 2008;
Doo, Chun, and Doo 2016; Alodhayani et al. 2017). Short
sleep duration (between 5 and 6 hours), indeed, increased the
risk of developing obesity (Alodhayani et al. 2017; Canuto
et al. 2014; Broussard and Van Cauter 2016). Interestingly,
the relationship between sleep duration and obesity risk
described a U-shaped relation (Grandner et al. 2015).
The aim of this manuscript is to provide an overview of
the current evidence on the association between obesity and
SD and viceversa, tempting to provide insights on the hor-
monal and nutritional mechanisms involved in these
associations.
2. Obesity as cause of sleep disturbance
Obesity is considered one of the most important risk factor
of SD (Marks and Landaira 2016; Xiao et al. 2016; Ma et al.
2017). An increase of 6 units in body mass index (BMI)
resulted in four time greater risk of OSA (Quintas-Neves,
Preto, and Drummond 2016) that is characterized by recur-
rent narrowing and closure of the upper airway, leading to
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intermittent oxyhemoglobin desaturation, sleep fragmenta-
tion and daytime sleepiness (Dewan, Nieto and Somers
2015). The excessive body size could represent a mechanical
barrier to normal breathing thus resulting in OSA that is
associated to frequent nocturnal awakenings, with impaired
SQ and sleep duration (Quintas-Neves, Preto, and
Drummond 2016; Shigeta et al. 2008; Tirado et al. 2017).
Nevertheless, both SQ and sleep duration might be
impaired in obese individuals without OSA. These data
come from an interesting study of Resta et al performed in
severe obese subjects without OSA (BMI 39.7 ± 5.94 kg/m2)
or diseases that are known to be associated with SD such as
endocrine, psychiatric, and neuromuscular diseases (Resta
et al. 2003). In this study, SD, characterized by choking,
awakening and unrefreshing sleep, were more frequent in
obese (17%, 25%, 50% and 50%, respectively) than in nor-
mal-weight subjects (2.5%, 1%, 3% and 9%, respectively). In
addition, these Authors reported that the percentage of
snoring was higher in obese subjects (47%) than in controls
(8.1), and the daytime sleepiness, evaluated by the Epworth
Sleepiness Scale (ESS), was lower in normal control group
(2.7 ± 2) than in obese subjects (7.7 ± 4.6), with a linear cor-
relation between ESS score and snoring severity
(P¼ 0.0169). Indeed, in addition to OSA, SD in obesity
could be due to other obesity-related pathological conditions,
such as functional gastrointestinal disorders, including irrit-
able bowel syndrome and functional dyspepsia (Dixon,
Schachter, and O’Brien 2001; Eslick and Talley 2016), nictu-
ria, asthma and ostearticolar pain (Dixon, Schachter, and
O’Brien 2001). Although obesity has been associated to SD,
several studies attempt to investigate if it was just obesity or
instead body composition that could have a role in explain-
ing the effect of the excess of weight on sleep. In both males
and females waist circumference (WC) has been reported to
be the most predictive factor of SD (Davidson and Patel
2008). These results were also confirmed in a study per-
formed in 463 community-dwelling older Spanish women
reporting a significant positive correlation between SD,
assessed by the Jenkins Sleep Scale, and WC. Since WC is
an indirect measure of visceral adipose tissue, the results of
these studies lead to hypothesize that visceral adipose tissue
could play an additional role in the pathogenesis of SD
(Moreno-Vecino et al. 2017). As well known visceral adipose
tissue is the main site of secretion of pro-inflammatory cyto-
kines, such as IL-1, IL-6 and TNF-a that determine chronic
low-grade inflammation (Hotamisligil 2006). Several studies
showed that pro-inflammatory cytokines could be involved
in sleep regulation and classified as “sleep-regulatory sub-
stances” (Gamaldo, Shaikh and McArthur 2012; Perrini et al.
2017). TNF-a and IL-1b, whose secretion follows a circadian
rhythm, with the highest TNF-a and IL-6 secretion during
the night (between 01:00 and 02:00 h), are involved in the
physiological regulation of sleep in both animals and
humans (Opp, Kapas and Toth 1992), playing an important
role in the slow-wave sleep (SWS) (Covelli et al. 1992). In
1997, Vgontzas et al showed that in overweight and obese
subjects with OSA, narcolepsy, idiopathic hypersomnia,
TNF-a and IL-6 levels were elevated during the morning
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TNF α, IL-1β, IL-6
Gastrointestinal Disorders
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Fat and Carbohidrates
Diet
Sleep Disturbances
Obesity
OSA
Figure 1. Mechanisms linking sleep disturbances and obesity. Obesity represents a risk factor of developing Sleep Disturbances. Several obesity-related factors
could interfere with normal sleep quality and/or duration. In particular the consumption of fat and carbohydrates, mostly in the evening, have been reported to
have a detrimental effect on sleep while the consumption of fibers is associated with more restorative and deeper sleep. Further, as well known the visceral adipose
tissue is the main source of cytokines that could have a role in disrupting the sleep. The gastrointestinal disorders such as irritable bowel syndrome and functional
dyspepsia could have an additional effect in disturbing the sleep quality. In addition severe obesity could be associated to OSA that is characterized by recurrent
narrowing and closure of the upper airway, leading to intermittent oxyhemoglobin desaturation, sleep fragmentation and daytime sleepiness. : posi-
tive effect; : negative effect
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(between 06:00 and 07:00 h), with a positive association
between TNFa and Il-6 with SD and BMI, respectively
(Vgontzas et al. 1997). Thus, a possible vicious circle operat-
ing within the interactions between obesity, pro-inflamma-
tory cytokines levels and sleep abnormality, could be
hypothesized (Figure 1).
Another important mechanism that relates obesity to SD
is represented by diet food components (Hargens et al.
2013). In fact dietary fatty acids have been reported to be
involved in sleep regulation, through their effect on the
dynamics of biochemical compounds, including complex lip-
ids, prostaglandins, neurotransmitters and aminoacids which
exert an important role for the initiation and maintenance
of sleep (Yehuda, Rabinovitz, and Mostofsky 1998; Irmisch
et al. 2007; St-Onge et al. 2016), indeed, showed that poor
diet quality (characterized by high fat and low fiber intake)
was associated with SD. In this study normal weight adults
subjects were randomized in two groups: short sleep (four
hours in bed) and normal sleep (nine hours in bed). After
4 days controlled diet, in the fifth day self-reported free diet
was allowed. Diet quality analysis revealed that free diet was
characterized by higher intake of saturated fatty acids, sugar
and/or non-sugar/non-fiber carbohydrates. During con-
trolled diet period, SQ did not differ between the two
groups. After free diet period, impaired sleep parameters
were observed, in particular, less slow wave sleep (SWS) and
longer sleep onset latency (SOL); in addition free diet was
associated with poor SQ (St-Onge et al. 2016). On the con-
trary polyunsaturated fatty acids and n-3 fatty acids have
been observed to be positively associated to SQ parameters,
after controlling for age, gender and obesity (Papandreou
2013). At first, fatty acids (specifically, n-3 and n-6 fatty
acid) contribute to the generation of prostaglandin D2
(PGD2), an inflammatory signaling molecule that has a role
in sleep regulation which is involved in the maintenance of
normal sleep (Mizoguchi et al. 2001); in addition, n-3 fatty
acids are related to the regulation of serotonergic neuro-
transmission, being serotonin a well-known substance that
promote the normal sleep and helps the melatonin produc-
tion (Machado and Suchecki 2016).
In addition to fat, a single carbohydrates-rich meal in the
evening has been reported to increase core body tempera-
ture ad heart rate and reduced nocturnal secretion of mela-
tonin within the eight hours after the end of the meal
consumption healthy normal weight subjects (Touitou,
Reinberg and Touitou 2017; Kr€auchi et al. 2002). On the
other hand, fiber consumption is associated with more
restorative and deeper sleep (St-Onge et al. 2016). These
findings suggest that diet quality might have a great influ-
ence on SQ, probably due to the effects of foods, or more
specifically nutrients, on hormonal responses and circadian
rhythms. In this context, the understanding of the relation-
ship between nutrition and sleep could pave the way to the
recent concept of chronobiology, or more specifically Chrono
nutrition, as a way for Nutritionists to manage not only
obesity and obesity-related diseases by using proper diets,
but also SD.
Finally, several evidence have widely demonstrated an
association between vitamin D deficiency and SD (McCarty
et al. 2013; Bertisch et al. 2015). Although no studies were
carried out in obese population, it could be hypothesized
that since vitamin D deficiency is a common finding in
obesity (Muscogiuri et al. 2010), it could act as an additional
detrimental factor on obesity-related SD.
3. Sleep disturbance as cause of obesity
3.1. Dietary factors
Although a number of evidence showed that obesity is one
of the main cause of SD, several studies investigate the role
of SD as predisposing risk factor of obesity (Hargens et al.
2013; Lyytikainen et al. 2011; Markwald et al. 2013;).
Indeed, several meta-analysis and systematic reviews showed
that subjects with SD or poor quality sleep are more prone
to develop obesity, in particular central obesity (Broussard
and Van Cauter 2016). A four-years follow-up prospective
study conducted on 14,000 young adults (24.3–34.7 years)
showed that self-reported short sleep persistent exposure
leads to an 1.45 times increase in obesity and elevated WC
development, suggesting that lower sleep duration may rep-
resent an important obesity risk factor, acting with a dose-
response association (Krueger et al. 2015). Similar results
were reported by Canuto et al. demonstrating that shift
work- induced sleep deprivation ( 5 hours of continuous
sleep per day) increases the risk of obesity compared to nor-
mal sleep duration (> 5 hours of continuous sleep per day)
(Canuto et al. 2014). A retrospective study performed by
Kubo and colleagues carried out on about 10,000 shift work-
ers reported that shift workers had an increased obesity risk
in a follow-up period of 6 years, compared to daytime work-
ers (Kubo et al. 2011).
The increased prevalence of obesity in subjects with sleep
restriction could be explained by an effect on calorie intake
(Cain et al. 2015). Subjects undergoing a simulated night
shift experienced a significant increased consumption of
high-fat foods compared to controls, although differences in
food amount or total caloric intake were not significant,
thus suggesting that an impaired SQ could lead to unhealthy
food cues and thus to an increased risk of develop-
ing obesity.
Modern lifestyle could contribute to alter our physio-
logical chronobiology. Both shift workers/businessmen and
young people tend to go to bed late and to wake up early,
resulting in a blunted sleep duration (Burman 2017;
Wittmann et al. 2006). This pathological condition has been
called “Social Jet-lag (S-jl)” and seems to be strongly linked
with increased risk of developing both obesity and metabolic
syndrome (Burman 2017; Espitia-Bautista et al. 2017; Pinto
et al. 2017) due to an excessive consumption of high caloric
food, carbohydrate and high fat-rich foods. Espita-Bautista
and colleagues investigated the effect of S-jl on metabolism
in an experimental model founding that S-jl can cause the
propensity towards an increased consumption of unhealthy
food resulting in obesity and obesity-related metabolic conse-
quences such as dyslipidaemia and hyperinsulinemia
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(Espitia-Bautista et al. 2017). Prolonged sleep restriction or
sleep duration of less than 6.5 hours has been associated to
unhealthy dietary patterns, mainly characterized by
increased consumption of high glycaemic index (GI) food
and beverages (Fels}o et al. 2017). Subjects with sleep disrup-
tion, indeed, tend to have a low quality diet (Hargens et al.
2013; Alodhayani et al. 2017; Markwald et al. 2013), includ-
ing increased carbohydrate intake (Hargens et al. 2013; Doo,
Chun, and Doo 2016; Moreno-Vecino et al. 2017; Markwald
et al. 2013), that might contribute to develop central obesity.
A study conducted on 4th and 7th grade children showed
that sleep pattern tightly influence food choice (Franckle
et al. 2015). During annual screening, students provided
information about diet and sleep. Results showed that
shorter sleepers (< 10 hours per day) consumed less fre-
quently vegetables and more frequently soda than other stu-
dents. A randomized cross-over study conducted on
adolescents evaluated the effects of sleep restriction (6.5 h in
the bed) versus normal sleep duration (10 h in the bed) on
food preferences (Simon et al. 2015). Short sleepers showed
more appealing towards sweets, higher sweets consumption
and calories intake, even if self-reported hunger was not
affected, suggesting that prolonged short sleep duration may
contribute to obesity and obesity-related disease develop-
ment, acting by this mechanism. The preferences of
unhealthy food could be ascribed to an increase in brain
activity in areas associated with reward, including the puta-
men, nucleus accumbens, thalamus, insula, and prefrontal
cortex in response to food stimuli, consequent to sleep
deprivation (St-Onge et al. 2012).
Sleep deprivation not only influences the food preferences
but also it is associated to an increased food intake. The
function of sleep in humans is to preserve energy and that
some of the energy saved is redistributed to support other
critical sleep-dependent physiological processes (Jung et al.
2011). Sleep restriction seems to lead to an increased energy
expenditure that in turn results in an increased food intake
in daytime, probably as a compensatory mechanism
(Broussard and Van Cauter 2016; Alodhayani et al. 2017,
Pinto et al. 2017). When the food intake overcomes the
energy expenditure, weight gain is the logical consequence.
Among the dietary factors that could improve SD,
tryptophan (Trp) deserves a prominent role. Tryptophan is
an essential amino acid in humans that must be absorbed in
the small intestine from protein-rich foods (for example,
milk, eggs, meat, and beans). As Trp is metabolized into
melatonin via the serotonin pathway, several previous stud-
ies have suggested that eating food rich in Tryptophan at
evening could improve nocturnal sleep quality in humans
(Wyatt et al. 1970). This could be due to the fact that
Tryptophan is the precursor of melatonin, a hormone that is
produced by the pineal gland and regulates sleep and
wakefulness.
3.2. Hormonal aspects
Several studies showed interesting correlations between SQ
and hormonal status. In particular, sleep restriction seems to
impair the hormonal system that regulate energy balance at
brain level and which involves different hormones, including
cortisol, insulin, ghrelin, leptin and melatonin (Hargens
et al. 2013; Taheri et al. 2004; Broussard and Van Cauter
2016; Pinto et al. 2017; St-Onge et al. 2012; Leproult and
Van Cauter 2010; Beccuti and Pannain 2011; Lowry et al.
2012) (Table 1).
3.3. Cortisol
There is an overall agreement across different studies that
sleep deprivation and/or reduced sleep quality is more com-
monly associated with a modest but functionally important
activation of the hypothalamus-pituitary-adrenal axis (HPA)
activity as the consequence of a chronic stress induced by
long-time altered sleep and consistent with a disorder of
central nervous system hyper arousal (Vgontzas and
Chrousos 2002; Kumari et al. 2009; Ruan et al. 2015; Balbo
et al. 2010). The impaired function of the HPA axis, in turn,
is involved in a number of healthy problems (Anagnostis
et al. 2009). In particular, high concentrations of cortisol are
recognized as one the main cause of impaired glucose
homeostasis, insulin-resistance, and visceral fat accrual (Di
Dalmazi et al. 2015). In addition, functional HPA hyper-
activity with increased cortisol levels are proposed as one of
Table 1. Mechanism of action of sleep disturbance-related hormones in promoting obesity.
Hormones Sleep disturbance – related changes Mechanism of action
Cortisol High cortisol levels causes overeating, impairs glu-
cose homeostasis, insulin-resistance, and increases
visceral fat accrual
Ghrelin High ghelin levels increase calorie intake, mostly
sweet foods
Leptin Sleep disturbance has been associated to leptin-
resistance and consequent increased leptin levels
which results in increased hunger.
Endocannabinoid System
2-arachidonoylglycerol (one of the most abundant
ligand of endocannabinoid receptors) rhythm is
amplified and the peak is delayed and extended,
increasing hunger
Melatonin Decreased levels of melatonin causes weight gain,
chronic inflammation and increased oxidative
stress, thus blunting glucose metabolism.
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the main cause of overeating in presence of palatable
foods 56.
3.4. Ghrelin
Insufficient sleep duration might induce changes in satiety
and hunger hormones, thereby altering food intake and EE
(Markwald et al. 2013).
In fact it has been reported an increase in ghrelin
(Markwald et al. 2013), which is an orexigen hormone, asso-
ciated to insufficient sleep duration (Broussard and Van
Cauter 2016; Beccuti and Pannain 2011). To investigate the
effect of sleep restriction on ghrelin levels, nineteen normal
weight (mean BMI: 23.1 ± 0.4 kg/m2) young healthy subjects
were recruited (Broussard and Van Cauter 2016).
Participants underwent a normal sleep (8.5 hours in bed for
4 consecutive nights) and restricted sleep (4.5 hours in bed
for 4 consecutive nights) period. SQ was assessed by poly-
somnography and diet strictly controlled by Nutritionists,
blood samples were collected within the 24 hours, and bio-
chemical parameters and hormones were assessed. Sleep
restriction significantly increased the diurnal and nocturnal
ghrelin profile, in particular during postprandial periods. As
expected, sleep restriction was also associated with increased
caloric intake, particularly higher carbohydrates intake.
Interestingly, increased ghrelin profile was associated with
higher sweets consumption.
3.5. Leptin
Several evidence showed that obese subjects with OSA have
higher circulating levels of leptin compared to non-OSA
obese subjects (Quintas-Neves, Preto, and Drummond 2016;
Beccuti and Pannain 2011; Marik 2000; Wolk,
Shamsuzzaman and Somers 2003), suggesting that OSA
exacerbate the leptin-resistance, which characterize the obes-
ity. In addition, OSA treatment with nasal continuous posi-
tive airway pressure (nCPAP) seems to improve the leptin
levels (Marik 2000). This mechanism could explain the
increased food intake in subjects with sleep disruption,
resulting in higher risk to develop obesity, overweight or
metabolic alterations.
3.6. Endocannabinoid system
The sleep deprivation could affect also the endocannabinoid
system which, in turn, regulates either food intake and
metabolism 70. In a well-designed clinical study, Hanlon and
colleagues (2015) showed that 2-arachidonoylglycerol (2-
AG), one of the most abundant ligand of endocannabinoid
receptors, follows a circadian secretion, with a peak in the
early mid-afternoon and a nadir in mid-sleep (Hanlon et al.
2015). According to these Authors, circadian levels of 2-AG
regulate the daytime food intake, suppressing hunger during
the sleep and enhancing it during mid-afternoon.
Interestingly, the same Authors, in another study, showed
that restricted sleep causes an increase in daily 2-AG circu-
lating levels (Hanlon et al. 2016). Healthy adults were
randomized in 2 groups: sleep restriction (4.5 hours) and
normal sleep (8.5 hours) for 4 nights. In restricted sleep
group, 2-AG rhythm was amplified and the peak was
delayed and extended. In addition, participants of this latter
group reported increased hunger and appetite in concomi-
tance with the afternoon peak of 2-AG, and an inability to
inhibit the palatable foods intake.
3.7. Melatonin
Subjects with SD showed decreased nocturnal levels of mela-
tonin. Melatonin is involved in sleep timing and is empiric-
ally used in the treatment of SD (Auld et al. 2017).
Melatonin is secreted in humans during the dark phase of
the light–dark circadian cycle but it exerts antioxidant, anti-
inflammatory and immune-modulatory effects (Reiter, Tan
and Fuentes-Broto 2010). In addition, several studies showed
that melatonin is involved also in the regulation of body
weight gain and energy metabolism in some rodents. In par-
ticular, the administration of melatonin in a model of obes-
ity-related type 2 diabetes, such as Z€ucker diabetic fatty rats,
has been shown to reduce obesity and to improve the low-
grade inflammation, oxidative stress, and the metabolic pro-
files in this strain of rats, without affecting food intake and
activity (Agil et al. 2013). Misalignment in circadian rhythm
and deficiency of melatonin, as the consequences of sleep
deprivation, have been accounted for one of the mechanisms
to explain why shift workers tend to gain weight (Touitou,
Reinberg and Touitou 2017). The possible links between the
deficiency of melatonin and obesity or its potential role in
the prevention of obesity and its complications have been
supported by several studies during recent decades (Cipolla-
Neto et al. 2014; Reiter et al. 2012; Szewczyk-Golec,
Wozniak and Reiter 2015). However, despite the growing
body of evidence indicating the association of melatonin
with obesity, the mechanisms of melatonin action are far
from being fully understood.
4. Conclusion
SD represents a common complications of obesity that could
contribute to the pathogenesis and/or to worsen obesity-
related complications. Thus, it is of paramount importance
to investigate SD in obese patients and to include the treat-
ment of SD in the management of obesity in order to pre-
vent or improve metabolic and cardiovascular diseases. On
the other hand, SD although not associated to obesity,
should not be underestimated because they could foster the
onset of hormonal and metabolic patterns that in turn
increase the total intake and the unhealthy food consump-
tion thus encouraging the weight gain.
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